Corvus Pharmaceuticals, Inc.
ANTI-CD73 ANTIBODIES
Last updated:
Abstract:
Provided herein are, inter alia, anti-CD73 antibodies and methods of using the same. The antibodies provided include amino acid substitution embodiments affecting the antibody glycosylation state. The antibodies provided herein are, inter alia, useful for the treatment of cancer and effective for inhibition of CD73 activity.
Status:
Application
Type:
Utility
Filling date:
27 Aug 2020
Issue date:
22 Jul 2021